Terbinafine Tablet
Product Images NDC 71205-152

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Terbinafine (NDC 71205-152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-152-30 (250mg 30tabs)

This is a description of a medication for oral usage. The package contains thirty tablets of Terbinafine 250mg manufactured by InvaGen Phamaceuticals, Inc. Each tablet contains Terbinafine HCI equivalent to 250mg of terbinafine. The tablets are white, round, and have a beveled edge with IG on one side and 209 on the other. This medication should be stored at 20°-25°C (68°-77°F) and should be kept out of reach of children. This medication is only available with a prescription. Lot #00000 is mentioned multiple times.*

FDA Label Image

Image 2 (Terbinafine Str)

FDA Label Image

Image 1 (Terbinafine Table)

This text appears to be presenting data related to adverse events and discontinuation rates for Terbinafine tablets versus Placebo. The text is showing the percentage of patients experiencing particular symptoms while taking these tablets, such as headache or gastrointestinal symptoms like diarrhea, dyspepsia etc. The text also notes the occurrence of dermatological symptoms, liver enzyme abnormalities and various sensory disturbances such as taste and vision.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.